BRPI0417371A - enoxaparina para o tratamento de cáncer - Google Patents

enoxaparina para o tratamento de cáncer

Info

Publication number
BRPI0417371A
BRPI0417371A BRPI0417371-6A BRPI0417371A BRPI0417371A BR PI0417371 A BRPI0417371 A BR PI0417371A BR PI0417371 A BRPI0417371 A BR PI0417371A BR PI0417371 A BRPI0417371 A BR PI0417371A
Authority
BR
Brazil
Prior art keywords
enoxaparin
cancer treatment
colon
prostate
lung
Prior art date
Application number
BRPI0417371-6A
Other languages
English (en)
Inventor
Andre Uzan
Umesh Shukla
Rita Samuel
Luis Toro-Figueroa
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0417371A publication Critical patent/BRPI0417371A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"ENOXAPARINA PARA O TRATAMENTO DE CáNCER". A presente invenção refere-se ao uso de enoxaparina para tratamento de uma doença ligada à modulação da atividade de heparanase, em particular cânceres de mama, pulmão, próstata, cólon ou pancreático.
BRPI0417371-6A 2003-12-04 2004-12-01 enoxaparina para o tratamento de cáncer BRPI0417371A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03293028A EP1537871A1 (en) 2003-12-04 2003-12-04 Enoxaparin for the treatment of cancer
PCT/EP2004/014807 WO2005053713A1 (en) 2003-12-04 2004-12-01 Enoxaparin for the treatment of cancer

Publications (1)

Publication Number Publication Date
BRPI0417371A true BRPI0417371A (pt) 2007-04-10

Family

ID=34443115

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417371-6A BRPI0417371A (pt) 2003-12-04 2004-12-01 enoxaparina para o tratamento de cáncer

Country Status (12)

Country Link
US (1) US20050164985A1 (pt)
EP (2) EP1537871A1 (pt)
JP (1) JP2007513123A (pt)
KR (1) KR20060109929A (pt)
AU (1) AU2004294730A1 (pt)
BR (1) BRPI0417371A (pt)
CA (1) CA2546292A1 (pt)
IL (1) IL175689A0 (pt)
MX (1) MXPA06006275A (pt)
NO (1) NO20063114L (pt)
WO (1) WO2005053713A1 (pt)
ZA (1) ZA200604409B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381410B2 (en) * 2003-03-12 2008-06-03 Vasgene Therapeutics, Inc. Polypeptide compounds for inhibiting angiogenesis and tumor growth
US20110236405A1 (en) * 2008-07-29 2011-09-29 Tel Hashomer Medical Research Infrastructure And Services Ltd. Coagulation factor modulation for controlling transplant organ size
EP2376613B8 (en) 2008-12-19 2018-06-06 Aktiebolaget SKF A machine part comprising a physical component coated with a polyelectrolyte layer
US20160129112A1 (en) * 2013-05-28 2016-05-12 Momenta Pharmaceuticals, Inc. Pharmaceutical Compositions Comprising Pyrophosphate
CN107075490A (zh) * 2014-08-20 2017-08-18 健康研究公司 用于预防和/或治疗erbb1阳性癌症的方法
CN110548045A (zh) * 2018-05-30 2019-12-10 北京大学 低分子肝素-抗肿瘤药物静电复合物纳米系统的制备方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492332B1 (en) * 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
CA2261231C (en) * 1996-07-23 2012-11-27 Nagase Biochemicals, Ltd. Process using ulkenia sp. to prepare docosahexaenoic acid and docosapentaenoic acid
IL129877A (en) * 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
US6541036B1 (en) * 1997-05-29 2003-04-01 Thomas Jefferson University Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR)
US6690976B2 (en) * 2000-04-13 2004-02-10 Celsion Corporation Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
DE10026699A1 (de) * 2000-05-30 2001-12-06 Basf Ag Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
DE10141106A1 (de) * 2001-08-22 2003-03-13 Aventis Pharma Gmbh Verwendung von Heparinoid-Derivaten zur Behandlung und Diagnose von mit Heparinoiden behandelbaren Erkrankungen
EP2402753A1 (en) * 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US6908907B2 (en) * 2002-04-22 2005-06-21 El-Naggar Mawaheb M. Prevention and treatment of tumor growth, metastasis, and thromboembolic complications in cancer patients

Also Published As

Publication number Publication date
US20050164985A1 (en) 2005-07-28
JP2007513123A (ja) 2007-05-24
NO20063114L (no) 2006-08-29
IL175689A0 (en) 2008-03-20
ZA200604409B (en) 2007-09-26
AU2004294730A1 (en) 2005-06-16
EP1537871A1 (en) 2005-06-08
WO2005053713A1 (en) 2005-06-16
CA2546292A1 (en) 2005-06-16
KR20060109929A (ko) 2006-10-23
EP1694340A1 (en) 2006-08-30
MXPA06006275A (es) 2006-08-23

Similar Documents

Publication Publication Date Title
BRPI0515352A (pt) métodos para tratamento de cáncer
RS20150135A1 (en) TREATMENT WITH ANTI-VEGF ANTIBODIES
BR9813085A (pt) Processo para o tratamento de tumores sólidos em um mamìfero, de doença neoplásica metastática em um mamìfero, de câncer de melanoma, mama, cólon, ovariano, renal, sistema nervoso central, bexiga, próstata ou pulmão em um humano, de doenças neoplásicas em um humano, de distúrbios hematopoiéticos em um mamìfero, composição farmacêutica oral utilizável para o tratamento de doenças neoplásicas em um humano, e, forma de dosagem unitária estéril
BR9811946A (pt) Método para prevenção ou tratamento de distúrbios e doenças dependentes de estrogênio
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
EP1961418A4 (en) USE OF ISOTHIOCYANATE-BASED COMPOUNDS IN THE TREATMENT OF PROSTATIC DISEASES AND SKIN CANCER
WO2007053573A3 (en) Treatment of cancer with sorafenib
HK1108284A1 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
SI1581812T1 (sl) Sestavki in postopki za diagnosticiranje in zdravljenje raka kolona
ES2391382T8 (es) Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
IL177645A0 (en) Phospholipid analogs for diagnosis and treatment of cancer
TW200509892A (en) Novel aminobenzophenone compounds
WO2003065006A3 (en) Methods and compositions for treating cancer
WO2009015050A3 (en) Gene expression profile for predicting ovarian cancer patient survival
BRPI0410633A (pt) piridopirazinas e uso das mesmas como moduladores de cinase
WO2004098377A3 (en) Methods and compositions for diagnosis and therapy of parkin-associated disorders
IL200410A0 (en) Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
WO2005118592A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
MX2007000360A (es) Marcadores moleculares de pronostico.
BRPI0607285A2 (pt) tratamento de tumores com metástases
BR0312294A (pt) Arilcarbonil piperazinas e hteroarilcarbonilpiperazinas e o uso das mesmas para tratamento de doenças benignas e malignas
BRPI0417371A (pt) enoxaparina para o tratamento de cáncer
WO2004110245A3 (en) Combination therapy for cancer treatment
ATE435224T1 (de) Neue piperidinsubstituierte diaminothiazole
BR0215689A (pt) Composição farmacêutica compreendendo arsênico para o tratamento de malignidade

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.